-
Global/EN
- Global
- North America
- Latin America
Heerlen, NL, 01 September 2022 08:00 CEST
Royal dsm-firmenich, a global purpose-led science-based company, today announces the completion of its acquisition of Prodap, a leading animal nutrition and technology company in Brazil, which was first announced on 7 June 2022.
Prodap is an animal nutrition and technology company that combines technology offerings, consulting services, and customized nutritional solutions to drive efficiency and sustainability in animal farming. By harnessing the power of Prodap’s digital solutions, dsm-firmenich will take another step forward in its Precision & Personalization journey. dsm-firmenich will strengthen and further develop its digital solutions to reach more markets globally, enabling smarter nutritional decision-making thanks to artificial intelligence and other tools. Prodap will complement dsm-firmenich’s deep animal nutrition knowledge and advisory capabilities with its extensive consultancy experience, facilitating an even higher level of customer experience. Additionally, by supporting more efficient farming, the acquisition contributes to dsm-firmenich’s commitment to enabling a double-digit reduction in on-farm livestock emissions by 2030 as part of its 2021 food system commitments.
dsm-firmenich is a global, purpose-led company in Health, Nutrition & Bioscience, applying science to improve the health of people, animals and the planet. dsm-firmenich’s purpose is to create brighter lives for all. dsm-firmenich’s products and solutions address some of the world’s biggest challenges while simultaneously creating economic, environmental and societal value for all its stakeholders – customers, employees, shareholders, and society at large. dsm-firmenich and its associated companies employ approximately 23,000 people around the world and deliver annual net sales of about €10 billion. The company was founded in 1902 and is listed on Euronext Amsterdam. More information can be found at https://www.dsm.com/.
01 September 2022
We detected that you are visitng this page from United States. Therefore we are redirecting you to the localized version.